Stem Cell Research Center Needs Overhaul, IOM Panel Says
By Marcia Frellick,
American Medical News
| 01. 08. 2013
[Quotes CGS's Marcy Darnovsky]
An Institute of Medicine review of California’s prominent center for stem cell research found organizational flaws and called for sweeping changes to reduce potential conflicts of interest.
The report praised the taxpayer-funded California Institute for Regenerative Medicine for its aggressive pace in awarding grants totaling $1.3 billion to 59 institutions, saying, “CIRM and those it has funded have set in motion a significant scientific enterprise.” However, the IOM found the center’s practices generate concerns about transparency and potential bias that could undermine support for the CIRM.
Reviewers found “far too many” CIRM board members represent organizations that were awarded grants or benefited from the grants. The majority of board members should be independent with no conflicting personal or professional interests, the committee said.
The CIRM definition of conflict of interest should be retooled to “include non-financial interests, such as the potential for personal conflicts of interest to arise from one’s own affliction with a disease or personal advocacy on behalf of that disease,” the report said (
iom.edu/~/media/Files/Report%20Files/2012/CIRM/CIRM_rb.pdf).
The IOM review called for the CIRM’s day-to-day operations to be...
Related Articles
By Julia Métraux, Mother Jones | 02.10.2026
Why was Jeffrey Epstein obsessed with genes? In the latest tranche of Epstein records and emails made available by the Department of Justice, themes of genes, genetics, and IQ—alongside more explicit threads of white supremacy—keep cropping up, often adjacent to Epstein’s...
By Teddy Rosenbluth, The New York Times | 02.09.2026
Dr. Mehmet Oz has urged Americans to get vaccinated against measles, one of the strongest endorsements of the vaccine yet from a top health official in the Trump administration, which has repeatedly undermined confidence in vaccine safety.
Dr. Oz, the...
By Ava Kofman, The New Yorker | 02.09.2026
1. The Surrogates
In the delicate jargon of the fertility industry, a woman who carries a child for someone else is said to be going on a “journey.” Kayla Elliott began hers in February, 2024, not long after she posted...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...